Agricultural Solutions Q3 2020 Sales in the Agricultural Solutions segment were considerably below the third quarter of 2019. Strong volumes growth and slightly higher prices could not offset the significantly negative currency effects. (XLSX:) XLS Factors influencing sales in Q3 2020 – Agricultural Solutions Volumes 11% Prices 2% Portfolio 0% Currencies (19%) Sales (6%) In Europe, sales were slightly above the prior-year quarter. Higher volumes and higher prices more than offset negative currency effects, especially in Turkey and eastern Europe. Sales were considerably lower in North America. Significantly higher sales volumes, especially of fungicides, could not compensate for lower price levels, especially for herbicides in a continuing challenging market environment, and negative currency effects. In Asia, sales rose slightly as a result of higher volumes, in particular in India and China. Negative currency effects had an offsetting impact. Prices were on a level with the prior-year quarter. Sales declined considerably in the region South America, Africa, Middle East. This was driven by significantly negative currency effects, particularly in Brazil. Much higher sales volumes, especially in Brazil, and significantly higher price levels could not offset this effect. Income from operations (EBIT) before special items declined considerably, mainly due to currency effects. EBIT for the third quarter of 2020 included a special impairment charge in connection with measures to streamline the glufosinate-ammonium production network. Compared with the previous quarter, the Agricultural Solutions segment recorded a considerable decline in sales and EBIT before special items due to seasonal factors. (XLSX:) XLS Segment data – Agricultural Solutions (Million €) Q3 January–September 2020 2019 +/– 2020 2019 +/– Sales to third parties 1,474 1,561 (6%) 6,059 6,006 1% Income from operations before depreciation, amortization and special items 201 250 (20%) 1,489 1,458 2% Income from operations before depreciation and amortization (EBITDA) 151 220 (31%) 1,393 1,368 2% Depreciation and amortizationa 455 177 157% 815 524 56% Income from operations (EBIT) (304) 43 . 578 844 (32%) Special items (330) (30) . (377) (90) . EBIT before special items 26 73 (64%) 955 934 2% Assets (September 30) 15,495 17,135 (10%) 15,495 17,135 (10%) Investments including acquisitionsb 108 179 (40%) 244 295 (17%) Research and development expenses 207 215 (4%) 614 613 0% a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) b Additions to property, plant and equipment and intangible assets back next